In Vivo Iterative Adjuvant Screening Identifies an Intranasal Vaccine Formulation for Elicitation of Protective Mucosal Immune Responses Against SARS-CoV-2
<b>Background:</b> Intranasal (I.N.) vaccination holds promise to elicit mucosal immunity that counters respiratory pathogens at the site of infection. For subunit protein vaccines, immunostimulatory adjuvants are typically required. <b>Methods:</b> We screened a panel of 22 lipid-phase adjuvants to...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2025-11-01
|
| Serija: | Pharmaceutics |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1999-4923/17/11/1422 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|